White label ELPA - ClinicalTrials.eu

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Not recruiting

3 1 1
Investigated diseases:
- Schizophrenia
+15
Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa

Not recruiting

3 1 1 1
Investigated diseases:
- Retinitis pigmentosa
Study on the Safety of Osimertinib with Radiation for Patients with Stage IV EGFR-Mutation Positive Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Study on Afatinib and Osimertinib for Patients with EGFR-Mutated, T790M Negative Non-Squamous Non-Small Cell Lung Cancer in First-Line Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study on Nivolumab and Ipilimumab for Patients with Advanced Urothelial Cancer After Initial Chemotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Transitional cell carcinoma metastatic
Study on the Effects of Leriglitazone in Male Children with Cerebral X-Linked Adrenoleukodystrophy Before Stem Cell Transplant

Not recruiting

2 1 1
Investigated diseases:
- Adrenoleukodystrophy
Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone receptor positive breast cancer
- Triple negative breast cancer
Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Not recruiting

3 1

+1
Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Not recruiting

3 1 1
Investigated diseases:
- Hormone-dependent prostate cancer
+3
Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated diseases:
- Colitis ulcerative
+13

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies